The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Vaccines for preventing malaria (SPf66)
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2006
|
| DOI | 10.1002/14651858.cd005966 |
| Pubmed ID | |
| Authors |
Patricia M Graves, Hellen Gelband |
| Abstract |
A malaria vaccine is badly needed. SPf66 was one of the earliest vaccines developed. It is a synthetic peptide vaccine containing antigens from the blood stages of malaria linked together with an antigen from the sporozoite stage, and is targeted mainly against the blood (asexual) stages. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 7 | 27% |
| United States | 2 | 8% |
| Armenia | 1 | 4% |
| Argentina | 1 | 4% |
| Unknown | 15 | 58% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 21 | 81% |
| Scientists | 2 | 8% |
| Practitioners (doctors, other healthcare professionals) | 2 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 169 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 1% |
| Tanzania, United Republic of | 1 | <1% |
| India | 1 | <1% |
| United Kingdom | 1 | <1% |
| Belgium | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 162 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 28 | 17% |
| Student > Master | 28 | 17% |
| Researcher | 23 | 14% |
| Student > Bachelor | 16 | 9% |
| Student > Postgraduate | 9 | 5% |
| Other | 30 | 18% |
| Unknown | 35 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 27% |
| Agricultural and Biological Sciences | 28 | 17% |
| Biochemistry, Genetics and Molecular Biology | 12 | 7% |
| Nursing and Health Professions | 6 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
| Other | 32 | 19% |
| Unknown | 40 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 70. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 March 2024.
All research outputs
#644,291
of 26,409,992 outputs
Outputs from Cochrane database of systematic reviews
#1,090
of 13,223 outputs
Outputs of similar age
#911
of 88,329 outputs
Outputs of similar age from Cochrane database of systematic reviews
#1
of 47 outputs
Altmetric has tracked 26,409,992 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,223 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.7. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 88,329 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.